Annual report
9989.TEDINET S100VZPP
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥801.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥751.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥690.5bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥634.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥44.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥41.0bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥43.8bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥41.7bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥38.1bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥38.2bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥43.6bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥41.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥30.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥25.7bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥30.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥29.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥444.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥420.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥360.7bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥325.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥308.5bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥174.3bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥269.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥253.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥236.3bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥220.6bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥205.2bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥65.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥69.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥65.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥69.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥86.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥41.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥37.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥35.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥74.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥28.5bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥10.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥22.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.3bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥262.91 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥249.07 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥219.83 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.68 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥219.82 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.63 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥2,305.89 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,164.06 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,020.97 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,886.4 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,754.32 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 60.7% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.5% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 7,145 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 6,662 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 6,371 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 6,015 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 5,634 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥485.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥463.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥433.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥415.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥413.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥25.6bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥24.7bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥24.8bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥25.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥23.2bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.3bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥24.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥24.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥25.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥17.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥17.8bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥15.7bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥14.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥18.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥300.3bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥298.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥255.1bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥244.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥235.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥122.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥123.2bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥178.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥175.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥169.6bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥163.9bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥157.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥35.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥40.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥150.38 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.95 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.69 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥127.09 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥134.68 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥127.09 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥160.12 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥130 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥114 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥71 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,524.29 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,496.02 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,450.09 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,401.22 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,344.86 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.0% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 119,331,184 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,413 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 4,090 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 3,895 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 3,795 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 3,517 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 51
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥57.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥57.8bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥25.5bn |
| Discount Storereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥14.6bn |
| Discount Storereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.0bn |
| Discount Storereportable segment | employees | at 2025-03-31 | 1798 pure |
| Discount Storereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥342.3bn |
| Discount Storereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥342.3bn |
| Discount Storereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥13m |
| Discount Storereportable segment | segment assets | at 2025-03-31 | ¥152.6bn |
| Discount Storereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥17.9bn |
| Drug Storereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥21.2bn |
| Drug Storereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥11.3bn |
| Drug Storereportable segment | employees | at 2025-03-31 | 5347 pure |
| Drug Storereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥517.3bn |
| Drug Storereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥459.6bn |
| Drug Storereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥57.8bn |
| Drug Storereportable segment | segment assets | at 2025-03-31 | ¥316.9bn |
| Drug Storereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥26.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥35.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥17.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥859.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥801.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥57.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥469.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥44.5bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥53.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥53.5bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | −¥27.4bn |
| Discount Storereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥13.8bn |
| Discount Storereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Discount Storereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥313.8bn |
| Discount Storereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥313.8bn |
| Discount Storereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥11m |
| Discount Storereportable segment | segment assets | at 2024-03-31 | ¥137.4bn |
| Discount Storereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥15.3bn |
| Drug Storereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥22.4bn |
| Drug Storereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥9.7bn |
| Drug Storereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥491.4bn |
| Drug Storereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥437.9bn |
| Drug Storereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥53.5bn |
| Drug Storereportable segment | segment assets | at 2024-03-31 | ¥310.2bn |
| Drug Storereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥805.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥751.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥53.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥447.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥41.0bn |
| Drug Storereportable segment | employees | at 2025-03-31 | 4413 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,641
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | 360672000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 420208000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 444007000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 1754.32 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 1886.40 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2020.97 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 2164.06 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 2305.89 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 216.68 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 204.02 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 219.83 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 249.07 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 262.91 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | 216.63 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | 204.01 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | 219.82 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.665 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.677 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.655 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.602 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.607 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.129 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.112 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.113 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.119 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.118 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 18.69 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 14.58 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 16.54 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 18.74 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 16.01 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 31761000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 31682000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 37380000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 41188000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 41164000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -17901000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -20659000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -28512000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -74850000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -35373000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -8064000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -8187000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -17326000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 22487000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -10600000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 86495000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 89330000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |